Cerenome (CNSY)CFO bought ~$10K

~$10K

Approx. value · 20K sh @ $0.51

68K

Holds after · shares reported

Traded

Nov 4, 2025

Filed

Nov 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 16, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
2. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 4, 2025 · this disclosureInsiderCFO purchased ~$10K of CNSY shares in the open market

What came next

1. Jan 13, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
2. Feb 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 9, 2026, Plus Therapeutics, Inc. (the “Company”) filed a Registration Statement on Form S-1 (File No. 333-292637) with the Securities and Exchange Commission (as amended, the “Registration Statement”).”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cerenome

OQRO holds no insider, Congress, fund or contract record for Cerenome dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CNSY page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cerenome

• SEC Form 4Aug 25, 2025

Everything OQRO holds on this company is on its CNSY page.